|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-3-12
|
|
pubmed:abstractText |
Immunotherapy is the most effective treatment against metastatic renal cell carcinoma (RCC). However, the response rate is approximately 15%. More effective therapy is, therefore, needed for patients with metastatic RCC. We then examined the antitumor effect of cationic multilamellar liposome containing human IFN-beta (huIFN-beta) gene (IAB-1) against RCC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1129-35
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12631618-Acridine Orange,
pubmed-meshheading:12631618-Animals,
pubmed-meshheading:12631618-Antineoplastic Agents,
pubmed-meshheading:12631618-Apoptosis,
pubmed-meshheading:12631618-Carcinoma, Renal Cell,
pubmed-meshheading:12631618-Cations,
pubmed-meshheading:12631618-Coloring Agents,
pubmed-meshheading:12631618-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:12631618-Gene Therapy,
pubmed-meshheading:12631618-Gene Transfer Techniques,
pubmed-meshheading:12631618-Humans,
pubmed-meshheading:12631618-Immunotherapy,
pubmed-meshheading:12631618-Interferon-beta,
pubmed-meshheading:12631618-Kidney Neoplasms,
pubmed-meshheading:12631618-Kinetics,
pubmed-meshheading:12631618-Liposomes,
pubmed-meshheading:12631618-Mice,
pubmed-meshheading:12631618-Mice, SCID,
pubmed-meshheading:12631618-Microscopy, Fluorescence,
pubmed-meshheading:12631618-Recombinant Proteins,
pubmed-meshheading:12631618-Time Factors,
pubmed-meshheading:12631618-Transfection,
pubmed-meshheading:12631618-Tumor Cells, Cultured
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Significant antitumoral activity of cationic multilamellar liposomes containing human IFN-beta gene against human renal cell carcinoma.
|
|
pubmed:affiliation |
Department of Urology, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
